Company news: Bod Australia; Zelira Therapeutics; Creso Pharma; Emyria; AusCann; Allied Corp by Martin Lane September 23, 2021September 23, 2021 Bod Australia Bod Australia has entered into an agreement with the Woolcock Institute of Medical Research […]
Company news: MGC Pharma; Emyria; ECS Botanics; Rua Bioscience; AusCann; Cannasouth; Cronos; Althea by Martin Lane September 2, 2021February 26, 2022
Company news: Bod; Emyria; Cann Group; Health House; Releaf Clinics; Creso Pharma; Greenfern; Medlab by Martin Lane August 26, 2021August 26, 2021
Cann Group and Emyria go their separate ways on S3 registration by Martin Lane August 13, 2021August 13, 2021
Company news: Emyria; Medibis; Incannex; Eqalis; Greenfern; Creso Pharma; Highlands Investments by Martin Lane August 12, 2021August 12, 2021
New evidence shows opioid use and pain decline, quality of life goes up after cannabis treatment by Martin Lane June 10, 2021June 16, 2021
Revealed: the studies that show medicinal cannabis could solve the opioid addiction crisis by Martin Lane May 13, 2021May 18, 2021
Emyria granted TGA approval for medical grade, smartphone-enabled, monitoring software by Martin Lane May 13, 2021May 13, 2021
Emyria and Cann Group ink deal to fast track over-the-counter CBD registration by Martin Lane March 29, 2021August 13, 2021